We are live on ! Find out more
FC

Financial Consulate Portfolio holdings

AUM $899M
1-Year Est. Return 20.23%
This Fund
S&P 500
This Quarter Est. Return
+6.27%
1 Year Est. Return
+20.23%
3 Year Est. Return
+53.33%
5 Year Est. Return
+41.52%
10 Year Est. Return
+193.14%
AUM
$708M
AUM Growth
+$202M
Cap. Flow
+$168M
Cap. Flow %
23.67%
Top 10 Hldgs %
67.13%
Holding
1,154
New
1,117
Increased
14
Reduced
14
Closed
1

Sector Composition

Rank Sector Weight
1 Miscellaneous 81.02%
2 Technology 6.46%
3 Financials 2.61%
4 Consumer Staples 2.41%
5 Industrials 1.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXC icon
1101
DXC Technology
DXC
$1.86B
$297 ﹤0.01%
+22
New +$312
UNIT
1102
Uniti Group
UNIT
$2.47B
$294 ﹤0.01%
+48
New +$287
DDD icon
1103
3D Systems Corp
DDD
$575M
$290 ﹤0.01%
+100
New +$206
CALY
1104
Callaway Golf Company
CALY
$2.84B
$285 ﹤0.01%
+30
New +$279
HIMS icon
1105
Hims & Hers Health
HIMS
$6.47B
$284 ﹤0.01%
+5
New +$256
RIGL icon
1106
Rigel Pharmaceuticals
RIGL
$909M
$284 ﹤0.01%
+10
New +$299
TDUP icon
1107
ThredUp
TDUP
$357M
$284 ﹤0.01%
+30
New +$284
XMTR icon
1108
Xometry
XMTR
$5.3B
$273 ﹤0.01%
+5
New +$217
BLDP
1109
Ballard Power Systems
BLDP
$706M
$272 ﹤0.01%
+100
New +$205
OUST icon
1110
Ouster
OUST
$2.63B
$271 ﹤0.01%
+10
New +$279
VSTM icon
1111
Verastem
VSTM
$743M
$265 ﹤0.01%
+30
New +$223
CLSD
1112
DELISTED
Clearside Biomedical
CLSD
$263 ﹤0.01%
+66
New +$450
BROS icon
1113
Dutch Bros
BROS
$6.43B
$262 ﹤0.01%
+5
New +$316
PCRX icon
1114
Pacira BioSciences
PCRX
$1.05B
$258 ﹤0.01%
+10
New +$246
HLF icon
1115
Herbalife
HLF
$1.3B
$254 ﹤0.01%
+30
New +$283
ORGO icon
1116
Organogenesis Holdings
ORGO
$220M
$254 ﹤0.01%
+60
New +$279
NCLH icon
1117
Norwegian Cruise Line
NCLH
$7.15B
$247 ﹤0.01%
+10
New +$243
SNV
1118
DELISTED
Synovus
SNV
$246 ﹤0.01%
+5
New +$256
PGEN icon
1119
Precigen
PGEN
$2.54B
$231 ﹤0.01%
+70
New +$198
LQDA icon
1120
Liquidia Corp
LQDA
$6.15B
$228 ﹤0.01%
+10
New +$217
FOA icon
1121
Finance of America Companies
FOA
$158M
$225 ﹤0.01%
+10
New +$250
ACAD icon
1122
Acadia Pharmaceuticals
ACAD
$4.83B
$214 ﹤0.01%
+10
New +$236
DSX icon
1123
Diana Shipping
DSX
$374M
$210 ﹤0.01%
+125
New +$207
DHT icon
1124
DHT Holdings
DHT
$3.36B
$192 ﹤0.01%
+16
New +$186
TLT icon
1125
iShares 20+ Year Treasury Bond ETF
TLT
$46.6B
$179 ﹤0.01%
+2
New +$175

Similar funds

Financial Consulate's Q3 2025 Portfolio in Review

As of Q3 2025, Financial Consulate held 1,154 positions worth $708M, up 40% from $507M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Financial Consulate deployed $168M of net new capital in Q3 2025, opening 1,117 new positions and adding to 14 existing holdings. Its largest new stake was Apple: 78,624 shares worth $20M.

By sector, the portfolio is most concentrated in Miscellaneous at 81% of assets, down from 99% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Schwab Fundamental US Broad Market Index ETF, an estimated $4.96M trimmed.

  • Financial Consulate's largest Q3 2025 buy was Apple: 78,624 shares worth $20M.
  • Financial Consulate added most to Schwab US Large- Cap ETF in Q3 2025, an estimated $10.9M increase.
  • Financial Consulate's biggest Q3 2025 reduction was Schwab Fundamental US Broad Market Index ETF, cutting an estimated $4.96M.
  • Financial Consulate fully exited 180 Degree Capital in Q3 2025, selling an estimated $1.46M.
  • Financial Consulate's ten largest holdings make up 67% of its $708M portfolio in Q3 2025.
  • Financial Consulate opened 1,117 new positions and closed 1 in Q3 2025.
  • Financial Consulate's portfolio value rose 40% quarter-over-quarter to $708M.

Based on Financial Consulate's 13F filing for Q3 2025, filed 21 Oct 2025.